Phase I study of danusertib (D) in combination with bevacizumab (B) in solid tumors.

Authors

Keywords

Journal

Volume 28, Issue 15_suppl, Pages 3066-3066

Publisher

American Society of Clinical Oncology (ASCO)

Online

2017-02-24

DOI

10.1200/jco.2010.28.15_suppl.3066

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started